Eosinophilic esophagitis is a progressive fibrostenotic disease. Proton pump inhibitors are a first-line treatment due to their anti-inflammatory effects. Might they also affect remodeling and fibrosis? An Editors’ Choice paper shares new findings. https://t.co/TksZc98tqx
Unique opportunity this morning @PhxChildrens to hear from our own Dr Shauna Schroeder and Dr Colby Sharlin together on the topic of eosinophilic esophagitis. Not only an important topic but an amazing example of our collaborative practice and mentorship of our junior faculty!
Great job by our first year peds GI fellow presenting at the Single Day Symposium @NASPGHAN 2024 meeting in Hollywood, Florida! Nice work Evan! #NASPGHAN24
Yesterday was truly amazing. Thank you to all that participated in our first GI Faculty Retreat. Even greater amount of gratitude to the junior faculty that had the faith to join us here @PhxChildrens Heart is full with what we are building here! Junior Faculty For Life! #JFFL
Tezepelumab, an anti-TSLP @AstraZeneca biologic drug, induced and maintained sustained remission of #EosinophilicEsophagitis for up to 21 months in an adolescent patients treated for asthma. Case report from @CincyChildrens published in @JACIInPractice https://t.co/cSPM2RxvNG
Bittersweet to have completed fellowship at the amazing place that is @CincyKidsGastro! So thankful for my co-fellows and the many mentors I have learned from here.
Looking forward to some time off and then starting my career as an attending @PhxChildrens later this summer!
Scientists at Cincinnati Children’s are tapping into #ArtificialIntelligence technology to learn more about a potential reservoir of harmful cells seen in active cases of eosinophilic esophagitis. https://t.co/2u5YEmeK1X
Omalizumab increases the reaction threshold for peanut and other common food allergies. A new study presented at the AAAAI Annual Meeting highlights a valuable option for safe and effective food allergy treatment. #omalizumab#FoodAllergies#AAAAI24
https://t.co/9obaPkjtxr
Amazing achievement by @CincyChildrens#GIFellow Dr. Courtney Bartel who received a @NASPGHAN award and gave an oral presentation on the correlation between inflam markers & #deepremission in #IBD
➡️ Drug clearance correlated more to DR than drug levels.
#biologics#pedsIBD